BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37331034)

  • 21. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients.
    Gouveia GR; Ferreira SC; Siqueira SAC; de Pádua Covas Lage LA; Hallack Neto AE; de Oliveira Costa R; Pereira J
    BMC Cancer; 2020 Oct; 20(1):1041. PubMed ID: 33121489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial.
    Kimani S; Painschab MS; Kaimila B; Kasonkanji E; Zuze T; Tomoka T; Mulenga M; Nyasosela R; Chikasema M; Mtangwanika A; Chawinga M; Mhango W; Nicholas S; Chimzimu F; Kampani C; Krysiak R; Lilly A; Randall C; Seguin R; Westmoreland KD; Montgomery ND; Fedoriw Y; Gopal S
    Lancet Glob Health; 2021 Jul; 9(7):e1008-e1016. PubMed ID: 34022150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma.
    Gao F; Wang ZF; Tian L; Dong F; Wang J; Jing HM; Ke XY
    Med Sci Monit; 2021 Aug; 27():e929898. PubMed ID: 34449759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation.
    Hori Y; Yamamoto H; Nozaki Y; Torisu T; Fujiwara M; Taguchi K; Nishiyama K; Nakamura S; Kitazono T; Oda Y
    Hum Pathol; 2020 Feb; 96():67-78. PubMed ID: 31734190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
    Bruno Ventre M; Ferreri AJ; Gospodarowicz M; Govi S; Messina C; Porter D; Radford J; Heo DS; Park Y; Martinelli G; Taylor E; Lucraft H; Hong A; Scarfò L; Zucca E; Christie D;
    Oncologist; 2014 Mar; 19(3):291-8. PubMed ID: 24567283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study.
    Michi Y; Harada H; Oikawa Y; Okuyama K; Kugimoto T; Kuroshima T; Hirai H; Mochizuki Y; Shimamoto H; Tomioka H; Kachi H; Sakamoto JI; Kayamori K; Yoda T
    BMC Oral Health; 2022 Jan; 22(1):20. PubMed ID: 35081952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
    Lin ZJ; Zha J; Yi SH; Li ZF; Ping LY; He XH; Yu HF; Zheng Z; Xu W; Chen FL; Xie Y; Chen BY; Zhang HL; Wang L; Ding KY; Li WY; Yang HY; Zhao WL; Qiu LG; Li ZM; Song YQ; Xu B
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):456-462. PubMed ID: 35968587
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunohistochemical subtyping of diffuse large B-cell lymphoma into germinal center B-cell and activated B-cell subtype, along with correlation of the subtypes with extranodal involvement, serum lactate dehydrogenase, and positron emission tomography scan-based response assessment to chemotherapy.
    Tyagi A; Abrari A; Khurana A; Tyagi S
    J Cancer Res Ther; 2022; 18(4):1129-1136. PubMed ID: 36149172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study.
    Ma J; Li Q; Shao J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2019; 11():10175-10185. PubMed ID: 31819650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
    Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma.
    Hong J; Yoon HH; Ahn HK; Sym SJ; Park J; Park PW; Ahn JY; Park S; Cho EK; Shin DB; Lee JH
    Acta Haematol; 2013; 130(4):305-11. PubMed ID: 24008775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases.
    Wang YG; Zhao LY; Liu CQ; Pan SC; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Medicine (Baltimore); 2016 Aug; 95(31):e4250. PubMed ID: 27495029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTER.
    Candelaria M; Oñate-Ocaña LF; Corona-Herrera J; Barrera-Carmona C; Ponce-Martínez M; Gutiérrez-Hernández O; Avilés-Salas A; Cacho-Díaz B
    Rev Invest Clin; 2019; 71(5):349-358. PubMed ID: 31599881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients.
    Luo H; Yi P; Wang W; Li K; Meng L; Li J; Zeng W; Tang M
    Med Sci Monit; 2019 Nov; 25():8671-8682. PubMed ID: 31734687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of extranodal involvement and its impact on survival in diffuse large B-cell lymphoma from a tertiary cancer center in rural India.
    Nair CK; Kurup AR; Manuprasad A; Shenoy PK; Raghavan V
    J Cancer Res Ther; 2021; 17(4):938-942. PubMed ID: 34528545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The diagnosis and treatment of colorectal Non-Hodgkin's lymphoma 32 cases].
    Zhou JL; Qiu HZ; Sun J; Li J
    Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):290-4. PubMed ID: 21612690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
    Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
    Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.